129 related articles for article (PubMed ID: 4008772)
1. Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
Morady F; DiCarlo LA; Baerman JM; Krol RB
J Am Coll Cardiol; 1985 Jul; 6(1):179-85. PubMed ID: 4008772
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
[TBL] [Abstract][Full Text] [Related]
3. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
4. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
5. Cycle length-dependent effects on normal and abnormal intraventricular electrograms: effect of procainamide.
Schmitt C; Kadish AH; Balke WC; Turk K; Buxton AE; Josephson ME; Marchlinski FE
J Am Coll Cardiol; 1988 Aug; 12(2):395-403. PubMed ID: 3392333
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
[TBL] [Abstract][Full Text] [Related]
7. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.
Marchlinski FE; Buxton AE; Josephson ME; Schmitt C
Circulation; 1989 Jan; 79(1):39-46. PubMed ID: 2910546
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.
Windle J; Prystowsky EN; Miles WM; Heger JJ
Clin Pharmacol Ther; 1987 Jun; 41(6):603-10. PubMed ID: 3581646
[TBL] [Abstract][Full Text] [Related]
9. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
[TBL] [Abstract][Full Text] [Related]
11. Frequency-dependent electrophysiologic effects of amiodarone in humans.
Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
[TBL] [Abstract][Full Text] [Related]
12. Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm.
Schmitt CG; Kadish AH; Marchlinski FE; Miller JM; Buxton AE; Josephson ME
Circulation; 1988 May; 77(5):1030-7. PubMed ID: 3359584
[TBL] [Abstract][Full Text] [Related]
13. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ
Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598
[TBL] [Abstract][Full Text] [Related]
14. Preferential effect of procainamide on the reentrant circuit of ventricular tachycardia.
Kay GN; Epstein AE; Plumb VJ
J Am Coll Cardiol; 1989 Aug; 14(2):382-90. PubMed ID: 2754127
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects of procainamide, mexiletine, and amiodarone on the transplanted heart. Experimental study.
Alvarez L; Escudero C; Torralba A; Millán I
J Thorac Cardiovasc Surg; 1995 May; 109(5):899-904. PubMed ID: 7739250
[TBL] [Abstract][Full Text] [Related]
16. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Naitoh N; Washizuka T; Takahashi K; Aizawa Y
Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
[TBL] [Abstract][Full Text] [Related]
18. Rate-dependent effects of procainamide on His-Purkinje conduction in man.
Gang ES; Denton TA; Oseran DS; Mandel WJ; Peter T
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1525-9. PubMed ID: 4003294
[TBL] [Abstract][Full Text] [Related]
19. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Long B; Koyfman A
J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
[TBL] [Abstract][Full Text] [Related]
20. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
